Trademark: 97131670
Status Date
Monday, November 6, 2023
Filing Date
Thursday, November 18, 2021
Published for Opposition
Tuesday, September 13, 2022
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; pharmaceutical anti-allergic preparations and substances; anti-infectives
Apr 11, 2024
Sou Teas Extension Received
Dec 20, 2023
Assignment Of Ownership Not Updated Automatically
Dec 19, 2023
Teas Change Of Correspondence Received
Dec 19, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 19, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 19, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 19, 2023
Teas Change Of Owner Address Received
Nov 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 6, 2023
Sou Extension 2 Granted
Nov 6, 2023
Sou Extension 2 Filed
Nov 6, 2023
Sou Teas Extension Received
May 9, 2023
Notice Of Approval Of Extension Request E-Mailed
May 5, 2023
Sou Extension 1 Granted
May 5, 2023
Sou Extension 1 Filed
May 5, 2023
Sou Teas Extension Received
Nov 8, 2022
Noa E-Mailed - Sou Required From Applicant
Sep 13, 2022
Official Gazette Publication Confirmation E-Mailed
Sep 13, 2022
Published For Opposition
Aug 24, 2022
Notification Of Notice Of Publication E-Mailed
Aug 8, 2022
Approved For Pub - Principal Register
Aug 8, 2022
Examiner's Amendment Entered
Aug 8, 2022
Notification Of Examiners Amendment E-Mailed
Aug 8, 2022
Examiners Amendment E-Mailed
Aug 8, 2022
Examiners Amendment -Written
Aug 3, 2022
Assigned To Examiner
Nov 23, 2021
New Application Office Supplied Data Entered
Nov 22, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24